4-(4-Ethylpiperazin-1-ylmethyl)phenylamine

Catalog No. :
ACDEMG258
CAS No. :
611225-86-6
Molecular Formula :
C13H21N3
Molecular Weight :
219.33

IUPAC Name:4-((4-ethylpiperazin-1-yl)methyl)aniline

4-(4-Ethylpiperazin-1-ylmethyl)phenylamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$139.00Login to see priceInquiryInquiry
10g95%$269.00Login to see priceInquiryInquiry
25g95%$538.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Ethylpiperazin-1-ylmethyl)phenylamine
IUPAC Name4-((4-ethylpiperazin-1-yl)methyl)aniline
MDL No.MFCD05237186
Molecular FormulaC13H21N3
Molecular Weight219.33
SMILESNC1=CC=C(CN2CCN(CC)CC2)C=C1
InChI KeyVVTIATCVLPUOPW-UHFFFAOYSA-N
Synonym611225-86-6 | 4-(4-ethylpiperazin-1-ylmethyl)phenylamine | 4-(4-Ethyl-piperazin-1-ylmethyl)-phenylamine | 4-[(4-ethylpiperazin-1-yl)methyl]aniline | 4-((4-ethylpiperazin-1-yl)methyl)aniline | MFCD05237186 | TimTec1_008481 | Benzenamine,4-[(4-ethyl-1-piperazinyl)methyl]
CAS No.611225-86-6
PubChem CID1084996

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACDEMG258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEKBU798 route compound structure diagram
    ACEKBU798414880-35-6
  2. Then
  3. ACDEMG258 route product structure diagram
    ACDEMG258611225-86-6
Inquiry

2. ACDEMG258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEKBU798 route compound structure diagram
    ACEKBU798414880-35-6
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACDEMG258 route product structure diagram
    ACDEMG258611225-86-6
Inquiry

Comments (0)